PSEUDOMONAS AERUGINOSA
Clinical trials for PSEUDOMONAS AERUGINOSA explained in plain language.
Never miss a new study
Get alerted when new PSEUDOMONAS AERUGINOSA trials appear
Sign up with your email to follow new studies for PSEUDOMONAS AERUGINOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Virus-Eating therapy inhaled to fight stubborn lung bug
Disease control CompletedThis study tested an inhaled treatment made from viruses that attack bacteria (phages) in 48 adults with bronchiectasis and chronic Pseudomonas lung infections. The goal was to see if the therapy could safely reduce the amount of bacteria in the lungs. Participants received eithe…
Matched conditions: PSEUDOMONAS AERUGINOSA
Phase: PHASE2 • Sponsor: Armata Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 07:16 UTC
-
Antibiotic shows promise against superbug infections
Disease control CompletedThis study looked at 200 adults with multi-drug resistant Pseudomonas infections who received the antibiotic ceftolozane-tazobactam. Researchers tracked how many patients survived 30 days and while in the hospital, and whether follow-up tests showed the infection was cleared. The…
Matched conditions: PSEUDOMONAS AERUGINOSA
Sponsor: Temple University • Aim: Disease control
Last updated May 26, 2026 07:11 UTC
-
Wash those paws! study tests dog disinfectant to stop hospital superbugs
Disease control CompletedThis study tested a special disinfectant wash for therapy dogs to see if it could stop the spread of dangerous germs like MRSA in hospitals. 45 children aged 3-17 took part. The goal was to keep animal-assisted therapy safe and sustainable by reducing infection risks.
Matched conditions: PSEUDOMONAS AERUGINOSA
Phase: PHASE4 • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated May 26, 2026 07:05 UTC
-
Scientists hunt superbug sources to stop untreatable infections
Knowledge-focused CompletedThis study aimed to create a smarter way to track a dangerous, drug-resistant bacteria called CRPA, which causes severe infections in hospitals. Researchers collected samples from patients, healthy people, and wet environments (like sinks and water) in the Netherlands, Italy, and…
Matched conditions: PSEUDOMONAS AERUGINOSA
Sponsor: Erasmus Medical Center • Aim: Knowledge-focused
Last updated May 18, 2026 12:12 UTC